Home   Search   Browse   Statistics   User guide   FAQs   Post question   Download   Process data  
Search results for the GEO ID: GSE24813
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM610739
GPL1261
BCL6 WT chip 1 untreated bone marrow, BCL6 WT, untreated strain: C57Bl6/129SV age: 4 weeks cell culture: BCR-ABL1 transformed myeloid cells disease state: BCR-ABL1-driven CML genotype/variation: BCL6 WT agent: untreated
GSM610742
GPL1261
BCL6 WT chip 2 untreated bone marrow, BCL6 WT, untreated strain: C57Bl6/129SV age: 4 weeks cell culture: BCR-ABL1 transformed myeloid cells disease state: BCR-ABL1-driven CML genotype/variation: BCL6 WT agent: untreated
GSM610776
GPL1261
BCL6 WT chip 1 Imatinib treated bone marrow, BCL6 WT, Imatinib treated strain: C57Bl6/129SV age: 4 weeks cell culture: BCR-ABL1 transformed myeloid cells disease state: BCR-ABL1-driven CML genotype/variation: BCL6 WT agent: Imatinib BCL6 WT CML cells were incubated with 10 µM STI571 (Imatinib) for 16 hours.
GSM610777
GPL1261
BCL6 WT chip 2 Imatinib treated bone marrow, BCL6 WT, Imatinib treated strain: C57Bl6/129SV age: 4 weeks cell culture: BCR-ABL1 transformed myeloid cells disease state: BCR-ABL1-driven CML genotype/variation: BCL6 WT agent: Imatinib BCL6 WT CML cells were incubated with 10 µM STI571 (Imatinib) for 16 hours.
GSM610842
GPL1261
BCL6 WT chip 1 Imatinib/RI-BPI treated bone marrow, BCL6 WT, Imatinib/RI-BPI treated strain: C57Bl6/129SV age: 4 weeks cell culture: BCR-ABL1 transformed myeloid cells disease state: BCR-ABL1-driven CML genotype/variation: BCL6 WT agent: Imatinib/RI-BPI BCL6 WT CML cells were incubated with 10 µM STI571 (Imatinib) and 20 µM RI-BPI for 16 hours.
GSM610857
GPL1261
BCL6 WT chip 2 Imatinib/RI-BPI treated bone marrow, BCL6 WT, Imatinib/RI-BPI treated strain: C57Bl6/129SV age: 4 weeks cell culture: BCR-ABL1 transformed myeloid cells disease state: BCR-ABL1-driven CML genotype/variation: BCL6 WT agent: Imatinib/RI-BPI BCL6 WT CML cells were incubated with 10 µM STI571 (Imatinib) and 20 µM RI-BPI for 16 hours.
GSM610858
GPL1261
BCL6 KO chip 1 untreated bone marrow, BCL6 KO, untreated strain: C57Bl6/129SV age: 4 weeks cell culture: BCR-ABL1 transformed myeloid cells disease state: BCR-ABL1-driven CML genotype/variation: BCL6 KO agent: untreated
GSM610859
GPL1261
BCL6 KO chip 2 untreated bone marrow, BCL6 KO, untreated strain: C57Bl6/129SV age: 4 weeks cell culture: BCR-ABL1 transformed myeloid cells disease state: BCR-ABL1-driven CML genotype/variation: BCL6 KO agent: untreated
GSM610860
GPL1261
BCL6 KO chip 1 Imatinib treated bone marrow, BCL6 KO, Imatinib treated strain: C57Bl6/129SV age: 4 weeks cell culture: BCR-ABL1 transformed myeloid cells disease state: BCR-ABL1-driven CML genotype/variation: BCL6 KO agent: Imatinib BCL6 KOCML cells were incubated with 10 µM STI571 (Imatinib) for 16 hours.
GSM610861
GPL1261
BCL6 KO chip 2 Imatinib treated bone marrow, BCL6 KO, Imatinib treated strain: C57Bl6/129SV age: 4 weeks cell culture: BCR-ABL1 transformed myeloid cells disease state: BCR-ABL1-driven CML genotype/variation: BCL6 KO agent: Imatinib BCL6 KOCML cells were incubated with 10 µM STI571 (Imatinib) for 16 hours.
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes